Article
Efficacy of remdesivir in high-risk non-hospitalized patients
April 1, 2022
Dr. Taghvaei Clinical question: Does the use of remdesivir therapy in symptomatic, non-hospitalized, COVID-19 patients reduce disease progression and hospitalization? Background: Remdesivir...
Article
Outpatient COVID-19 therapeutics reduce hospitalization and mortality
February 10, 2022
Matching the right patient to the right therapeutic at the right time In late 2021 and early 2022, the Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for the...
Article
Aspirin increases the risk of clinically significant gastrointestinal bleeding in older persons
February 3, 2022
Clinical question: Does aspirin impact the risk of clinically significant gastrointestinal (GI) bleeding compared with placebo in community-dwelling older persons (aged >/= 70 years)? Dr....
Article
Effect of vasopressin and methylprednisolone versus placebo on return of spontaneous circulation in patients with in-hospital cardiac arrest
January 7, 2022
Dr. Miller Clinical question: Does the administration of vasopressin and methylprednisolone during in-hospital cardiac arrest improve the likelihood of return of spontaneous circulation...
News
Post-op remote monitoring may help catch drug errors, ease pain
October 5, 2021
"Virtual care with RAM technologies that measured heart rate, blood pressure, temperature, oxygen saturation, and body weight allowed for a large absolute difference in identifying the drug errors."
![1]()
News
Akathisia: “Ants in the Pants”
February 22, 2021
If left unresolved, akathisia can torment patients to sheer exhaustion.
![1]()
News
Predicting patient risk of medication-related harm
November 18, 2020
Clinicians can calculate the risk of a patient suffering medication-related harm post-discharge.
News
Dapagliflozin trial in CKD halted because of high efficacy
March 30, 2020
An independent data monitoring committee recommended stopping the trial.
News
New ASAM guideline released amid COVID-19 concerns
March 20, 2020
During the COVID-19 pandemic, “it is especially important” for clinicians to ensure that individuals with OUD continue to receive evidence-based care, said Dr. Paul H. Earley.
News
Pathways to new therapeutic agents for human coronaviruses
February 13, 2020
Researchers have been identifying old and new therapeutics to target metabolic pathways and modes of infection for human coronaviruses.
